Researchers at the Cincinnati Children’s Hospital Medical Center have identified a novel pathway they call the RIPIL-33 pathway that assembles in many types of epithelial cells upon exposure to various unrelated environmental allergens and processes the cytokine IL-33 into an active form within the cell to aid cellular recognition of the allergens. The new rapid reaction system may hold the key to understanding and treating people suffering from a wide range of allergies.